R

Revive Therapeutics
RVV

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CA$10.46M
EV
CA$10.48M
Shares Outstanding
418.56M
Beta
1.40

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2015E
-
P/Revenue 2015E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Revive Therapeutics Ltd.

gainify

R

Revive Therapeutics Ltd.

RVV

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing ...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Frank, Michael

Employees

2

IPO Date

2013-07-12

Headquarters

The Canadian Venture Building, 82 Richmond Street East, Toronto, Ontario, M5C 1P1, Canada

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.